Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 20034-02-0 | MDL No. : | MFCD01874328 |
Formula : | C9H10N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GUVUEQHXSSOYNR-UHFFFAOYSA-N |
M.W : | 162.19 | Pubchem ID : | 679482 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 47.19 |
TPSA : | 48.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.58 cm/s |
Log Po/w (iLOGP) : | 1.45 |
Log Po/w (XLOGP3) : | 1.0 |
Log Po/w (WLOGP) : | 1.21 |
Log Po/w (MLOGP) : | 0.75 |
Log Po/w (SILICOS-IT) : | 2.3 |
Consensus Log Po/w : | 1.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.96 |
Solubility : | 1.76 mg/ml ; 0.0109 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.62 |
Solubility : | 3.93 mg/ml ; 0.0242 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.12 |
Solubility : | 0.124 mg/ml ; 0.000764 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.56 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With hydrogenchloride In water for 3 h; Reflux | (5-Methyl-1H-benzimidazole-2-yl)-methanol 25 was prepared using the Phillips procedure [1], 4-Methyl-1,2-phenylenediamine (12.22 g; 0.1 mol) and glycolic acid (11.40 g; 0.15 mmol) in hydrochloric acid (50 ml, 5.5 M) were heated under reflux with for 3 h. The reaction mixture was cooled to room temperature and ammonia solution was added and the mixture cooled in ice until a bright brown precipitate formed. The resulting solid was recrystallised from aqueous ethanol to give (5-methyl-1H-benzimidazole-2-yl)-methanol as a pale creamy powdery solid Yield 100percent. |
72% | at 130℃; for 3 h; | General procedure: To a mixture of 1a–1c (10 mmol) with glycolic acid (2.28 g, 30 mmol) was added concentrated H3PO4(20 mL). The reaction mixture was refluxed at 130°C for 3 h, then quenched with 20percent NaOH. The respective solid product was collected by filtration. |
70% | at 150℃; for 3 h; | Step 1 The mixture of 4-methyl-benzene-1,2-diamine (500 mg, 4.10 mmol) and hydroxy-acetic acid (374 mg, 4.92 mmol) was heated to 150° C. with stirring for 3 hrs. After cooled to room temperature, the reactant was purified by silica gel column (DCM/MeOH=30/1) to afford (5-methyl-1H-benzoimidazol-2-yl)-methanol (400 mg, yield: 70percent) as a yellow solid. |
[ 4589-66-6 ]
(1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)methanol
Similarity: 0.82
[ 540516-28-7 ]
2-(Hydroxymethyl)-5-bromobenzimidazole
Similarity: 0.78
[ 6953-65-7 ]
(6-Chloro-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.78
[ 4856-97-7 ]
(1H-Benzoimidazol-2-yl)methanol
Similarity: 0.78
[ 6758-34-5 ]
(5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.73
[ 887571-32-6 ]
N-Methyl-1-(5-methyl-1H-benzo[d]imidazol-2-yl)methanamine
Similarity: 0.82
[ 4589-66-6 ]
(1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)methanol
Similarity: 0.82
[ 540516-28-7 ]
2-(Hydroxymethyl)-5-bromobenzimidazole
Similarity: 0.78
[ 2849-93-6 ]
1H-Benzimidazole-2-carboxylic acid
Similarity: 0.78
[ 6953-65-7 ]
(6-Chloro-1H-benzo[d]imidazol-2-yl)methanol
Similarity: 0.78